Vaughan, Ontario, Date:21- May-2025 Something big is going on in Vaughan, Ontario. Biotech company Tailored Genes, has chosen the city […]
In an era where speed, precision, and innovation are redefining the boundaries of science, Tailored Genes, a Toronto-Based Viral vector
Abstract The use of gene therapy (GT) for the treatment of primary immune deficiencies (PID) including severe combined immune deficiency
The recent announcement of AstraZeneca’s C$820 million investment in Canada is a testament to the nation’s emergence as a global
Canada is rapidly emerging as a global powerhouse in biomanufacturing, with increased investment in research, training, and infrastructure. With initiatives
Traditional cancer treatments, including chemotherapy and radiation, have long been the standard of care. However, gene therapy presents a new
At Tailored Genes, we believe that every scientific breakthrough starts with a partnership built on trust, precision, and bold ambition.
As global demand for gene therapy manufacturing soars, we’re seeing a growing strain on capacity, timelines, and reliability. Between the
Founded in 2014, Tailored Genes delivers custom lentivirus (LVV) and adeno‑associated virus (AAV) vectors, stable cell lines, and molecular biology GMP solutions to biotech and academic institutions—at cost‑effective prices.
© 2025. All rights reserved.
